Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale.
- DOI
- 10.1016/j.cct.2026.108437
- Published
- 2026 Oct
- Container
- Contemporary clinical trials
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cct.2026.108437,
title = {Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale.},
author = {Winhusen TJ and Lofwall MR and Nunes EV and Kropp F and Otterstatter M and Fanucchi LC and Vena A and Ghitza UE},
year = {2026},
journal = {Contemporary clinical trials},
doi = {10.1016/j.cct.2026.108437},
url = {https://doi.org/10.1016/j.cct.2026.108437}
}RIS
TY - JOUR TI - Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale. AU - Winhusen TJ AU - Lofwall MR AU - Nunes EV AU - Kropp F AU - Otterstatter M AU - Fanucchi LC AU - Vena A AU - Ghitza UE PY - 2026 JO - Contemporary clinical trials DO - 10.1016/j.cct.2026.108437 UR - https://doi.org/10.1016/j.cct.2026.108437 ER -
APA
TJ, W., MR, L., EV, N., F, K., M, O., LC, F., A, V., & UE, G. (2026). Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale.. Contemporary clinical trials. https://doi.org/10.1016/j.cct.2026.108437
Source records
- pubmed · retrieved 2026-09-25T18:12:31.717Z